glp-1 obesity drug news today october 23 2025 How Supply and Demand for Weight Loss Drugs is Playing Out in 2026 Outlook for obesity in 2025:
Description
For many years, there has only been one oral GLP-1 available: Rybelsus
A 2025 real-world safety comparison found the two drugs had distinct safety profiles, rather than one being safer overall
Molecular mechanisms of GLP-1 agonists for neuroprotection GLP-1 receptors are functionally expressed in insulin-releasing neuroglia form cells in the rat cerebral cortex, and hyperglycemia significantly increases GLP-1 receptor expression
Diabetes Care 40(10):e139e140
Density distribution of free fatty acid receptor 2 (FFA2)-expressing and GLP-1-producing enteroendocrine L cells in human and rat lower intestine, and increased cell numbers after ingestion of fructo-oligosaccharide
These include FDA-approved Ozempic substitutes and personalized alternatives like compounded semaglutide
